Partner
Charles Collins-Chase focuses on district court patent litigation and appeals before the U.S. Court of Appeals for the Federal Circuit, where he served as a clerk. He uses his chemical engineering background to help clients protect innovations in pharmaceuticals and biotechnology, energy and renewables, and chemical products. He has assisted numerous clients in Hatch-Waxman (ANDA) litigation.
Charles has handled district court litigations at every stage, from pre-litigation through discovery, dispositive motions, and trial. He particularly enjoys writing briefs and motions.
Charles has extensive experience at the Federal Circuit, where he has argued cases and assisted clients in more than thirty appeals from district courts and the Patent Trial and Appeal Board (PTAB). He has particular experience in appeals involving patent eligibility under 35 U.S.C. § 101. He represented the petitioners in Bilski v. Kappos before the U.S. Supreme Court and filed a Federal Circuit amicus brief on behalf of Genetic Alliance in the Myriad Genetics case.
Charles has broad expertise in clean energy and renewable technologies. He has handled litigation, appeals, and due diligence matters involving technologies ranging from renewable diesel fuel and biofuels to pollution control systems and biobased polymers.
Before law school, Charles completed an M.Phil. in engineering for sustainable development at the University of Cambridge, where he researched the feasibility of community-scale biodiesel production using a novel reactor system. His undergraduate thesis research involved synthesizing and characterizing thermosetting polymers made from soybean oil and other renewable resources.
Charles also devotes substantial time to pro bono matters and leads the firm’s pro bono committee. He argues before the Federal Circuit on behalf of veterans seeking service-connected disability benefits. He successfully represented a client seeking Social Security disability benefits, writing the briefs and arguing at a hearing before an administrative law judge.
Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.
Representing Bial in district court Hatch-Waxman litigation involving the anti-epileptic drug Aptiom®.
1:18-cv-00304, D. Del., Judges Connolly, Burke
Bay Materials, LLC v. 3M Company
1:21-cv-01610, D. Del., Judges Andrews, Hall
AbbVie Inc. et al v. Alvotech hf.
1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
Daicel Corporation v. Celanese International Corp.
Successfully represented Celanese International Corp. as lead counsel in two Federal Circuit appeals from IPR proceedings involving industrial acetic acid production, obtaining affirmance of the PTAB’s rulings in Celanese’s favor.
18-2130, -2131, Fed. Cir.
E. I. du Pont de Nemours v. Synvina C.V.
Represented DuPont and ADM in a successful Federal Circuit appeal from an IPR proceeding, resulting in reversal of the PTAB’s decision and invalidation of all challenged claims of Synvina’s patent directed to production of 2,5-furan dicarboxylic acid.
17-1977, Fed. Cir.
Dialware Communications, LLC v. Hasbro, Inc.
Lead counsel for Dialware Communications in a Federal Circuit appeal from a district court decision invalidating five patents under 35 U.S.C. § 101.
17-1952, Fed. Cir.
Event
Pharma & Biotech Patent Litigation Europe 2024 Pharma & Biotech Patent Litigation Europe 2024
January 22-24, 2024
Amsterdam
Articles
The Future of AI in the Pharmaceutical Industry The Future of AI in the Pharmaceutical Industry
April 27, 2023
European Pharmaceutical ManufacturerArticles
Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences
January 2023
International Pharmaceutical IndustryFederal Circuit IP Blog
Podcast Series: Last Month at the Federal Circuit - November 2022 Podcast Series: Last Month at the Federal Circuit - November 2022
November 22, 2022
Press Release
46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll 46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll
June 3, 2022
Commentary
Finnegan Taps Its Federal Circuit Chops for Military Vets in Disability Cases Finnegan Taps Its Federal Circuit Chops for Military Vets in Disability Cases
August 16, 2021
The AmLaw Litigation DailyMedia Mention
Litigator of the Week Runners-Up and Shout Outs Litigator of the Week Runners-Up and Shout Outs
August 6, 2021
The AmLaw Litigation DailyPress Release
Finnegan Secures Federal Circuit Victory in Veterans Benefits Case Finnegan Secures Federal Circuit Victory in Veterans Benefits Case
June 30, 2021
Commentary
One Year on: How Counsel Tackle Federal Circuit Briefs Rulings One Year on: How Counsel Tackle Federal Circuit Briefs Rulings
April 16, 2021
Managing Intellectual PropertyDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.